Adam P. Mecca

Donanemab in Early Symptomatic Alzheimer Disease

John R. Sims, Jennifer A. Zimmer, Cynthia Evans et al. · JAMA · 2023 · 2.6K citations · Full text

Medicine, Neurology, Neuroscience +17

Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging

Ming-Kai Chen, Adam P. Mecca, Mika Naganawa et al. · JAMA Neurology · 2018 · 448 citations · Full text

Medicine, Neurobiology, Neuroscience +17

Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1–7)

Justin L. Grobe, Adam P. Mecca, Melissa Lingis et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2006 · 333 citations

Medicine, Cardiology, Pharmacology +8

In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET

Adam P. Mecca, Ming‐Kai Chen, Ryan S. O’Dell et al. · Alzheimer s & Dementia · 2020 · 298 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Protection from angiotensin II‐induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats

Matthew J. Huentelman, Justin L. Grobe, Jorge Vázquez et al. · Experimental Physiology · 2005 · 235 citations · Full text

Medicine, Cardiology, Pharmacology +14